Die Daten über das Medikament Eisai-Biogen Alzheimer bestätigen Vorteile: FDA.

Published Date: 10 Jun 2023

Staff from the US Food and Drug Administration claimed on Wednesday that evidence from a late-stage trial of Eisai and Biogen's Alzheimer's disease medication suggests that patients received a significant benefit.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TULSA Is Effective in Long-Term Prostate Cancer Control.

2.

AVD Chemo Regimen Shows Promise in Older Patients With HL

3.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

4.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

5.

New Nanoparticles Can Destroy Undruggable Cancer Proteins


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot